Inaktiver Wert

LA JOLL Aktie Nasdaq

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

La Jolla : Pharmaceutical Company : Receives Positive Opinion from European Orphan Committee for LJPC-401	11.09.15
La Jolla : Pharmaceutical Company : Announces Pricing of Underwritten Offering of Common Stock	10.09.15
La Jolla : Pharmaceutical Company : Announces Proposed Underwritten Offering of Common Stock	09.09.15
La Jolla : Pharmaceutical Company : Receives Orphan Drug Designation for Two Novel Compounds for Fibrodysplasia Ossificans Progressiva	18.08.15
La Jolla : Pharmaceutical Company : and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors	18.08.15

Sektor